Publications:

In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses.

Nature Communications

Guo, Yuxin Y; Wang, Shao-Zhe SZ; Zhang, Xinping X; Jia, Hao-Ran HR; Zhu, Ya-Xuan YX; Zhang, Xiaodong X; Gao, Ge G; Jiang, Yao-Wen YW; Li, Chengcheng C; Chen, Xiaokai X; Wu, Shun-Yu SY; Liu, Yi Y; Wu, Fu-Gen FG

Publication Date: 2022-11-01

Variant appearance in text: VEGF: R22a

PubMed Link: 36319625

Variant Present in the following documents:

• 41467_2022_33831_MOESM2_ESM.pdf

View BVdb publication page

Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells.

Plos One

Otoshi, Taiyo T; Tanaka, Tomoaki T; Morimoto, Kazuya K; Nakatani, Tatsuya T

Publication Date: 2015

Variant appearance in text: VEGF: R22A

PubMed Link: 26713736

Variant Present in the following documents:

• Main text
• pone.0145769.pdf

View BVdb publication page

CXCL10 can inhibit endothelial cell proliferation independently of CXCR3.

Plos One

Campanella, Gabriele S V GS; Colvin, Richard A RA; Luster, Andrew D AD

Publication Date: 2010-09-13

Variant appearance in text: VEGF: R22A

PubMed Link: 20856926

Variant Present in the following documents:

• Main text
• pone.0012700.pdf

View BVdb publication page

The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan.

Molecular Therapy : The Journal Of The American Society Of Gene Therapy

Yang, Jinming J; Richmond, Ann A

Publication Date: 2004-06

Variant appearance in text: VEGF: R22A

PubMed Link: 15194051

Variant Present in the following documents:

• Main text

View BVdb publication page